Core Insights - Profusa, Inc. is set to launch an AI-driven physician portal in early 2026 within the European Economic Area (EEA), integrating its Lumee™ oxygen monitoring technology with NVIDIA's NeMo for enhanced clinical workflows [1][4] - The company aims to provide real-time biochemistry data to improve healthcare outcomes, linking therapeutic decisions with immediate biochemical changes [2][4] - The portal will facilitate remote patient monitoring and enhance the accuracy of personalized sensor data by connecting with electronic medical records (EMR) [1][4] Company Overview - Profusa is a commercial stage digital health company based in Berkeley, California, focused on developing tissue-integrated sensors for continuous monitoring of biochemistry [5] - The company is led by experienced management and a scientific team, aiming to deliver affordable and long-lasting biosensors for personal and medical use [5] Technology and Features - The physician portal will translate raw optical signals into reliable biometrics, providing actionable clinical insights rather than just dashboards [3][4] - Key features of the portal include integration with EMRs, remote physiologic monitoring, and a longitudinal health data graph that combines various health data sources [7]